title: Improvement of dental development in osteopetrotic mice by maternal vitamin D3 sulfate administration.
abstract: Utilizing the microphthalamic mouse, (mi/mi) as a model of osteopetrosis, vitamin D3 (cholecalciferol) was administered prenatally and postnatally to study its effects on tooth development and subsequent eruption. It has previously been reported that vitamin D3 crosses the placental barrier and is absorbed into mammary gland milk. Fifteen heterozygotes (+/mi) were used as breeders. There were three study groups: A) 5.0 ng/gm cholecalciferol sulfate; B) 2.5 ng/gm cholecalciferol sulfate; and C) no therapy. Intraperitoneal injections were administered three times per week, beginning when pregnancy was evident, and continuing for 4 additional weeks during lactation. Approximately half of the 59 offspring were sacrificed at age 1 day and the other half at 4 weeks. The former group was studied for crown development, and the latter group was studied for root development and eruption. When the osteopetrotic offspring of group A were compared with osteopetrotic offspring of group C, crown development and tooth eruption were substantially more advanced. Parameters examined were maturity of the ameloblasts and odontoblasts, dentin and enamel formation, root sheath development, status of eruption, and degree of apex closure. It was concluded that cholecalciferol sulfate significantly improves tooth development and subsequent eruption in the osteopetrotic mouse. A genetic disease has had its phenotype modified by vitamin therapy during gestation.
authors.affiliation: Harvard School of Dental Medicine, Boston, MA 02115.
authors.forename: T
authors.initials: T
authors.lastname: Perkins
authors.forename: D P
authors.initials: DP
authors.lastname: Trickler
authors.forename: G
authors.initials: G
authors.lastname: Shklar
mesh_terms: D000818:Animals; D002762:Cholecalciferol / Q000008:administration & dosage / Q000627:therapeutic use* / Q000031:analogs & derivatives; D005260:Female; D006580:Genetic Carrier Screening; D008431:Maternal-Fetal Exchange; D051379:Mice; D008817:Mice, Mutant Strains; D010022:Osteopetrosis / Q000188:drug therapy* / Q000196:embryology / Q000473:pathology; D011247:Pregnancy; D012016:Reference Values; D014059:Tongue / Q000187:drug effects / Q000196:embryology / Q000473:pathology; D014083:Tooth Germ / Q000187:drug effects / Q000473:pathology
chemical_list: C026415:vitamin D3 sulfoconjugate; D002762:Cholecalciferol